Top compounds associated with response to CLDN10


Feature Type Standardized
Nominal ANOVA
mRNA WP1130 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.01 0.8
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC -0.01 0.8
mRNA BIBW2992 FIMM pan-cancer AAC -0.049 0.8
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.0099 0.8
mRNA LFM-A13 GDSC1000 pan-cancer AAC 0.01 0.8
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.0086 0.8
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0099 0.8
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.0083 0.8
Download CSV